| Sigma Labs, Inc. | ||||||||
| Condensed Statements of Operations | ||||||||
| (Unaudited) | ||||||||
| Three Months Ended | ||||||||
| March 31, 2018 | March 31, 2017 | |||||||
| REVENUES | $ | 103,415 | $ | 114,523 | ||||
| COST OF REVENUE | 73,795 | 74,534 | ||||||
| GROSS PROFIT | 29,620 | 39,989 | ||||||
| OPERATING EXPENSES: | ||||||||
| Salaries & Benefits | 398,657 | 438,210 | ||||||
| Stock-Based Compensation | 161,522 | 139,632 | ||||||
| Operating R&D Costs | 121,977 | 54,505 | ||||||
| Investor & Public Relations | 180,399 | 265,146 | ||||||
| Legal & Professional Service Fees | 138,423 | 99,638 | ||||||
| Office Expenses | 95,106 | 84,205 | ||||||
| Depreciation & Amortization | 47,321 | 46,148 | ||||||
| Other Operating Expenses | 33,725 | 32,010 | ||||||
| Total Operating Expenses | 1,177,130 | 1,159,494 | ||||||
| INCOME FROM OPERATIONS | (1,147,510 | ) | (1,119,505 | ) | ||||
| OTHER INCOME (EXPENSE) | ||||||||
| Interest Income | 13,167 | 343 | ||||||
| State Incentives | - | 152,068 | ||||||
| Change in fair value of derivative liabilities | - | 93,206 | ||||||
| Interest Expense | - | (49,316 | ) | |||||
| Debt discount amortization | - | (56,441 | ) | |||||
| Loss on Disposal of Assets | (36,733 | ) | - | |||||
| Total Other Income (Expense) | (23,366 | ) | 139,860 | |||||
| LOSS BEFORE PROVISION FOR INCOME TAXES | (1,170,876 | ) | (979,645 | ) | ||||
| Provision for Income Taxes | - | - | ||||||
| Net Loss | $ | (1,170,876 | ) | $ | (979,645 | ) | ||
| Net Loss per Common Share - Basic and Diluted | $ | (0.23 | ) | $ | (0.26 | ) | ||
| Weighted Average Number of Shares Outstanding - Basic and Diluted | 4,997,534 | 3,835,875 | ||||||
